title: hOCT1 transcript levels and single nucleotide polymorphisms as predictive factors for response to imatinib in chronic myeloid leukemia.
authors.forename: A
authors.initials: A
authors.lastname: Bazeos
authors.forename: D
authors.initials: D
authors.lastname: Marin
authors.forename: A G
authors.initials: AG
authors.lastname: Reid
authors.forename: G
authors.initials: G
authors.lastname: Gerrard
authors.forename: D
authors.initials: D
authors.lastname: Milojkovic
authors.forename: P C
authors.initials: PC
authors.lastname: May
authors.forename: H
authors.initials: H
authors.lastname: de Lavallade
authors.forename: P
authors.initials: P
authors.lastname: Garland
authors.forename: K
authors.initials: K
authors.lastname: Rezvani
authors.forename: J F
authors.initials: JF
authors.lastname: Apperley
authors.forename: J M
authors.initials: JM
authors.lastname: Goldman
authors.forename: L
authors.initials: L
authors.lastname: Foroni
authors.forename: J S
authors.initials: JS
authors.lastname: Khorashad
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001549:Benzamides; D016044:Fusion Proteins, bcr-abl / Q000235:genetics / Q000378:metabolism; D006801:Humans; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy* / Q000235:genetics* / Q000473:pathology; D050811:Octamer Transcription Factor-1 / Q000235:genetics* / Q000378:metabolism; D010879:Piperazines / Q000627:therapeutic use*; D020641:Polymorphism, Single Nucleotide / Q000235:genetics*; D011379:Prognosis; D011743:Pyrimidines / Q000627:therapeutic use*; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D020133:Reverse Transcriptase Polymerase Chain Reaction
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D050811:Octamer Transcription Factor-1; C494165:POU2F1 protein, human; D010879:Piperazines; D011743:Pyrimidines; D012333:RNA, Messenger; D000068877:Imatinib Mesylate; D016044:Fusion Proteins, bcr-abl